Health Care System Mandates COVID Shot, Withdraws Religious and Medical Exemptions
Froedtert Health, a health care system headquartered in Wauwatosa, Wisconsin, is withdrawing religious and medical exemptions held by employees who had originally refused to get the messenger RNA (mRNA) COVID-19 shots. The company informed its employees that they must now get vaccinated with the recently approved Novavax’s COVID vaccine NVX-CoV2373 (also known as “Nuvaxovid” and […]
German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions
Techniker Krankenkasse, Germany’s largest health insurance company, reported that 437,593 of 11 million (1 in 25) insured individuals in 2021 had to undergo medical treatment as a result of adverse reactions from COVID-19 shots.1 COVID shots currently approved for use in Germany include Novavax’s Nuvaxovid, Moderna’s Spikevax, Pfizer/BioNTech’s Comirnaty, Johnson & Johnson/Janssen’s Ad26.COV2.S, AstraZeneca/Oxford University’s […]
Japanese Government Pays Family for Death Tied to COVID Shot
On July 25, 2022, a committee of Japan’s Ministry of Health, Labor and Welfare announced that it would provide a lump-sum death benefit of ¥44.2 million ($324,000), plus an additional ¥212,000 for funeral expenses, to the family of an elderly woman who died shortly after receiving a COVID-19 shot. The committee determined there was a […]
Nuvaxovid Offered as Alternative to mRNA Shots
For a virus (SARS-CoV-2) that many scientists and public health officials have maintained originated in a bat and accidently crossed over into humans, leading to the COVID-19 pandemic, it is odd that there does not appear to be much concern about producing vaccines that use genetic material from animals. You would think that this would […]
How the Novavax Coronavirus Vaccine Uses Moth Cells
As companies like Moderna and Pfizer race to use cutting-edge mRNA technology to deliver the first set of coronavirus vaccines, Novavax took a different approach. The Maryland biotechnology company used insect cells to produce the coronavirus’s unique spiked protein, which can then be introduced to patients to prime their immune systems. This process is known […]
FDA Grants EUA for Novavax’s COVID Vaccine
Opinion | On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax to distribute its experimental two-dose NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine for use by adults. The decision was expected, given the favorable recommendation by the FDA’s Vaccines and Related Biological Products Advisory […]
